Search Results - "Kuruvilla, Tarun"
-
1
Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol
Published in Cochrane database of systematic reviews (01-07-2013)“…Autopsy studies suggest that Wernicke-Korsakoff syndrome (WKS) is not a rare disorder, particularly in individuals who abuse alcohol. Thiamine has been…”
Get more information
Journal Article -
2
Neuroimaging in dementia: an update for the general clinician
Published in Progress in neurology and psychiatry (Guildford) (01-03-2016)“…Structural neuroimaging is a fundamental part of a routine dementia assessment to rule out treatable causes of cognitive impairment, and to support early,…”
Get full text
Journal Article -
3
Lecanemab for Alzheimer's disease: new hope or another false dawn?
Published in Progress in neurology and psychiatry (Guildford) (01-01-2023)Get full text
Journal Article -
4
Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease
Published in Brain (London, England : 1878) (01-09-2018)“…The relationship between microglial activation and protein aggregation in Alzheimer's disease is still debated. Dani et al. report that in vivo microglial…”
Get full text
Journal Article -
5
Trauma‐informed approach to managing behaviour in dementia
Published in Progress in neurology and psychiatry (Guildford) (01-04-2024)“…Causes of behaviour that challenge in dementia are often thought to be due to reversible factors, such as a urine infection or disrupted sleep‐wake cycle. In…”
Get full text
Journal Article -
6
Dissociative identity disorder: a review of the diagnosis that divides
Published in Progress in neurology and psychiatry (Guildford) (01-04-2024)“…The diagnosis of dissociative identity disorder (DID) has been associated with controversy and remains an area of dispute among clinicians to this day. This…”
Get full text
Journal Article -
7
The Role of Hormone Replacement Therapy (HRT) for the Prevention of Alzheimer's Disease in Postmenopausal Women
Published in Progress in neurology and psychiatry (Guildford) (01-07-2024)“…Alzheimer's disease (AD) disproportionately affects women and, in 2022, was the leading cause of female deaths. It has major psychosocial, physical and…”
Get full text
Journal Article -
8
Artificial intelligence as an aid to diagnosing dementia: an overview
Published in Progress in neurology and psychiatry (Guildford) (01-07-2021)“…Artificial intelligence (AI) is showing huge promise in assisting with early diagnosis of dementia, which would yield clear benefits in optimising the quality…”
Get full text
Journal Article -
9
Blood‐based biomarkers for Alzheimer's disease
Published in Progress in neurology and psychiatry (Guildford) (01-10-2022)“…Blood‐based biomarkers for identifying Alzheimer's disease (AD) pathology have been of considerable interest over the past decade and can offer a significant…”
Get full text
Journal Article -
10
Service provision for young-onset dementia in the UK
Published in Progress in neurology and psychiatry (Guildford) (01-07-2015)“…In this review article, Drs Rayment and Kuruvilla look at the problems faced by younger people with dementia, the current state of care delivery in the country…”
Get full text
Journal Article -
11
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial
Published in Lancet neurology (01-11-2021)“…Drugs modifying angiotensin II signalling could reduce Alzheimer's disease pathology, thus decreasing the rate of disease progression. We investigated whether…”
Get full text
Journal Article -
12
Delayed‐onset post‐traumatic stress disorder symptoms in dementia
Published in Progress in neurology and psychiatry (Guildford) (01-07-2017)“…Post‐traumatic stress disorder (PTSD) is commonly associated with working‐age adults and remains largely unrecognised in the elderly. In this review, Clara…”
Get full text
Journal Article -
13
Aducanumab and disease modifying treatments for Alzheimer's disease
Published in Progress in neurology and psychiatry (Guildford) (01-07-2021)“…Aducanumab has recently been licensed by the Food and Drug Administration (FDA) in the USA under its ‘accelerated approval’ pathway (to provide earlier access…”
Get full text
Journal Article -
14
Optimising and Future-Proofing Dementia Care With Amnestic Mild Cognitive Impairment (aMCI) Clinics
Published in BJPsych open (01-07-2023)“…Aims Amnestic Mild Cognitive Impairment (aMCI) is considered a pre-dementia (prodromal) phase of Alzheimer's disease (AD), with a higher probability in…”
Get full text
Journal Article -
15
Service provision for young-onset dementia in the UK: Young-onset dementia services
Published in Progress in neurology and psychiatry (Guildford) (01-07-2015)Get full text
Journal Article -
16
A qualitative evaluation of a research champions initiative in an NHS Trust
Published in Progress in neurology and psychiatry (Guildford) (01-10-2022)“…Promoting research in NHS trusts is known to be beneficial for patient outcomes and clinicians’ attitudes towards research and recruitment to studies. Here the…”
Get full text
Journal Article -
17
Evidence for neuroinflammation in Alzheimer's disease
Published in Progress in neurology and psychiatry (Guildford) (01-09-2016)“…New understanding in neuroscience has established that alongside the amyloid plaques, neurofibrillary tangles and atrophy, the neuroinflammation triggered by…”
Get full text
Journal Article -
18
Population‐based screening for dementia: a role for 6CIT?
Published in Progress in neurology and psychiatry (Guildford) (01-03-2016)Get full text
Journal Article -
19
Population‐based screening for dementia: controversy and current status
Published in Progress in neurology and psychiatry (Guildford) (01-01-2016)Get full text
Journal Article -
20
Confusion‐inducing drugs in a memory assessment service: an audit
Published in Progress in neurology and psychiatry (Guildford) (01-07-2018)“…A commonly encountered problem within memory services is the identification of medications that cause cognitive side‐effects. Here, the authors report on the…”
Get full text
Journal Article